Covered recipient · General Payments record
REBEKAH JO TIDWELL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$2,488.27
- Reported across 119 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $739.86 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $276.88 | 18 |
| Gilead Sciences, Inc. | $158.60 | 6 |
| Organon LLC | $71.32 | 1 |
| PFIZER INC. | $47.43 | 3 |
| Braeburn Inc. | $42.78 | 2 |
| Indivior Inc. | $35.09 | 1 |
| Astellas Pharma US Inc | $28.35 | 1 |
| ITI, Inc. | $26.08 | 1 |
| Merck Sharp & Dohme Corporation | $20.75 | 1 |
| Sumitomo Pharma America, Inc. | $18.68 | 1 |
| Axsome Therapeutics, Inc. | $13.90 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.52 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108311079 | CMS |
| ABBVIE INC. | $16.27 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108311081 | CMS |
| ABBVIE INC. | $16.60 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108311083 | CMS |
| ABBVIE INC. | $18.31 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108311085 | CMS |
| ABBVIE INC. | $16.15 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108311087 | CMS |
| ABBVIE INC. | $7.28 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108311089 | CMS |
| ABBVIE INC. | $26.62 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108311091 | CMS |
| ABBVIE INC. | $5.53 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108311093 | CMS |
| ABBVIE INC. | $23.31 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108311095 | CMS |
| ABBVIE INC. | $14.01 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108311097 | CMS |
| ABBVIE INC. | $15.25 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108311099 | CMS |
| ABBVIE INC. | $13.66 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108311101 | CMS |
| ABBVIE INC. | $18.03 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108311103 | CMS |
| ABBVIE INC. | $8.25 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108311105 | CMS |
| ABBVIE INC. | $16.50 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108311107 | CMS |
| ABBVIE INC. | $12.47 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108311109 | CMS |
| ABBVIE INC. | $14.45 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108311111 | CMS |
| ABBVIE INC. | $19.67 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108311113 | CMS |
| Astellas Pharma US Inc | $28.35 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139467476 | CMS |
| Axsome Therapeutics, Inc. | $13.90 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148402619 | CMS |
| Braeburn Inc. | $15.55 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125621045 | CMS |
| Braeburn Inc. | $27.23 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125621041 | CMS |
| Gilead Sciences, Inc. | $28.43 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133680418 | CMS |
| Gilead Sciences, Inc. | $27.64 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133680420 | CMS |
| Gilead Sciences, Inc. | $27.27 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133680422 | CMS |
| Gilead Sciences, Inc. | $24.81 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133680424 | CMS |
| Gilead Sciences, Inc. | $24.20 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133680426 | CMS |
| Gilead Sciences, Inc. | $26.25 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133680428 | CMS |
| Indivior Inc. | $35.09 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144573661 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $26.08 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143616643 | CMS |
| Merck Sharp & Dohme LLC | $20.75 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141963028 | CMS |
| Organon Llc | $71.32 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136261862 | CMS |
| PFIZER INC. | $15.38 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131503916 | CMS |
| PFIZER INC. | $14.97 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131551136 | CMS |
| PFIZER INC. | $17.08 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131514336 | CMS |
| Sumitomo Pharma America, Inc. | $18.68 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148999784 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.